Published in Neurosurgery on June 01, 1997
VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest (1999) 2.08
Pathways for aberrant angiogenesis in pancreatic cancer. Mol Cancer (2003) 1.61
Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series. J Neurooncol (2012) 1.00
Complications after gamma knife radiosurgery for benign meningiomas. J Neurol Neurosurg Psychiatry (2003) 0.98
The potential involvement of E-cadherin and beta-catenins in meningioma. PLoS One (2010) 0.97
Molecular biology of unreresectable meningiomas: implications for new treatments and review of the literature. Skull Base (2008) 0.83
Usefulness of thallium-201 SPECT in the evaluation of tumor natures in intracranial meningiomas. Neuroradiology (2011) 0.82
The Quantitative analysis of bFGF and VEGF by ELISA in human meningiomas. Mediators Inflamm (2006) 0.75
Differentiation of benign angiomatous and microcystic meningiomas with extensive peritumoral edema from high grade meningiomas with aid of diffusion weighted MRI. Biomed Res Int (2014) 0.75
Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005. J Clin Oncol (2015) 0.75
Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma in vitro. Oncotarget (2017) 0.75
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther (2000) 4.33
Posterior capsule opacification. Surv Ophthalmol (1992) 3.90
Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology (2001) 2.96
Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis. Oncogene (2008) 2.48
Elective stenting of the extracranial carotid arteries. Circulation (1997) 2.39
The elastic properties of the lens capsule in capsulorhexis. Am J Ophthalmol (1991) 2.30
HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res (2001) 2.29
"Cyclodiode". Trans-scleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma. Ophthalmology (1997) 2.27
Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc Natl Acad Sci U S A (1998) 2.11
Leukoencephalopathy associated with cobalamin deficiency. Neurology (1996) 2.11
Normalizing motor-related brain activity: subthalamic nucleus stimulation in Parkinson disease. Neurology (2006) 2.05
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors. Proc Natl Acad Sci U S A (2000) 1.99
Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell (1993) 1.97
Differential gene expression profiling in human brain tumors. Physiol Genomics (2001) 1.88
Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas. Clin Cancer Res (1999) 1.84
Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells. J Biol Chem (1995) 1.71
The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. Brain (2001) 1.70
Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen. J Clin Oncol (2005) 1.63
Do adaptive changes in metabolic rate favor weight regain in weight-reduced individuals? An examination of the set-point theory. Am J Clin Nutr (2000) 1.61
Phase specific analysis of herpes zoster associated pain data: a new statistical approach. Stat Med (2001) 1.60
Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Res (1998) 1.59
Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins. Gene Ther (1998) 1.57
An experimental study comparing various anterior capsulectomy techniques. Arch Ophthalmol (1991) 1.57
Demyelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus. J Virol (2000) 1.55
Human astrocytoma cells express a unique chloride current. Neuroreport (1996) 1.50
Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors. Cancer Res (1997) 1.45
Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma. Proc Natl Acad Sci U S A (1995) 1.41
Bayesian monitoring of phase II trials in cancer chemoprevention. J Clin Epidemiol (1999) 1.41
The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors. Proc Natl Acad Sci U S A (1996) 1.41
A controlled study of efficacy of interstitial or external irradiation in a virus-induced brain-tumor model in rats. J Neurosurg (1989) 1.39
Method of preparing emergency medicine residents for giving legal depositions. J Am Osteopath Assoc (1999) 1.39
Membranes from T and B lymphocytes have different patterns of tyrosine phosphorylation. Proc Natl Acad Sci U S A (1984) 1.38
The use of sequential self-obtained vaginal smears for detecting changes in the vaginal flora. Sex Transm Dis (1997) 1.37
A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency. Am J Hum Genet (2007) 1.36
Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia. J Urol (1999) 1.35
Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg (1995) 1.33
Thrombosis of the deep venous drainage of the brain in adults. Analysis of seven cases with review of the literature. Arch Neurol (1995) 1.32
Relationships between socioeconomic status and race-specific cervical cancer incidence in the United States, 1973-1992. J Health Care Poor Underserved (1998) 1.31
Protein kinase C activity is required for aryl hydrocarbon receptor pathway-mediated signal transduction. Mol Pharmacol (1998) 1.31
Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors. J Cell Sci (1995) 1.29
Human malignant glioma therapy using anti-alpha(v)beta3 integrin agents. J Neurooncol (2000) 1.29
Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine. J Biol Chem (1997) 1.28
Dietary determinants of dental caries and dietary recommendations for preschool children. J Public Health Dent (2000) 1.25
Genetically engineered HSV in the treatment of glioma: a review. Rev Med Virol (2000) 1.24
The ATF site mediates downregulation of the cyclin A gene during contact inhibition in vascular endothelial cells. Mol Cell Biol (1995) 1.24
Autofluorescence in normal and malignant human oral tissues and in DMBA-induced hamster buccal pouch carcinogenesis. J Oral Pathol Med (1998) 1.23
Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial. Ophthalmology (2000) 1.22
Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cells. Biochem Pharmacol (1998) 1.20
Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol (1996) 1.20
Inflammatory cells in solid murine neoplasms. II. Cell types found throughout the course of Moloney sarcoma regression or progression. Int J Cancer (1976) 1.20
High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI. Magn Reson Med (2009) 1.19
Septicaemia due to Pasteurella pneumotropica. J Clin Pathol (1973) 1.19
Pathophysiologic basis of surgery for Parkinson's disease. Neurology (2000) 1.19
Functional regulation of xanthine oxidoreductase expression and localization in the mouse mammary gland: evidence of a role in lipid secretion. J Physiol (2002) 1.18
Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor. Cancer (1998) 1.18
Carotid stent-supported angioplasty: a neurovascular intervention to prevent stroke. Am J Cardiol (1996) 1.17
Bilateral subthalamotomy in Parkinson's disease: initial and long-term response. Brain (2005) 1.16
Disappearance of cyclin A correlates with permanent withdrawal of cardiomyocytes from the cell cycle in human and rat hearts. J Clin Invest (1995) 1.16
Studies on the role of macrophages in regulation of growth and metastasis of murine chemically induced fibrosarcomas. Int J Cancer (1975) 1.16
Mitogenic activity elaborated by macrophage-like cell lines acts as competence factor(s) for BALB/c 3T3 cells. J Cell Physiol (1982) 1.15
Transforming growth factor-beta 1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleukin-1 beta in rat smooth muscle cells. J Biol Chem (1994) 1.14
Inflammatory cells in solid murine neoplasms. IV. Cytolytic T lymphocytes isolated from regressing or progressing Moloney sarcomas. J Immunol (1977) 1.14
Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy. Cancer (2000) 1.14
Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc Natl Acad Sci U S A (1993) 1.14
Autonomic activities in hyperhidrosis patients before, during, and after endoscopic laser sympathectomy. Neurosurgery (1994) 1.14
Outcomes of primary trabeculectomy with the use of adjunctive mitomycin. Arch Ophthalmol (1998) 1.14
Vascular endothelial growth factor induces manganese-superoxide dismutase expression in endothelial cells by a Rac1-regulated NADPH oxidase-dependent mechanism. FASEB J (2001) 1.12
Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas. Clin Cancer Res (2000) 1.10
Inflammatory cells in solid murine neoplasms. III. Cytotoxicity mediated in vitro by macrophages recovered from disaggregated regressing Moloney sarcomas. J Immunol (1977) 1.09
Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors. Cancer Res (1999) 1.09
Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. J Clin Invest (1996) 1.08
Expression of a restrictive receptor for interleukin 13 is associated with glial transformation. J Neurooncol (2000) 1.08
Expression of voltage-activated chloride currents in acute slices of human gliomas. Neuroscience (1998) 1.08
Preparation and study of human eyes obtained postmortem with the Miyake posterior photographic technique. Ophthalmology (1990) 1.07
Ionizing radiation improves survival in mice bearing intracranial high-grade gliomas injected with genetically modified herpes simplex virus. Clin Cancer Res (1999) 1.07
Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas. Int J Cancer (2000) 1.05
Engineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumors. Cancer Gene Ther (2006) 1.05
Evidence for mononuclear phagocytes in solid neoplasms and appraisal of their nonspecific cytotoxic capabilities. Contemp Top Immunobiol (1980) 1.04
Egr-1 gene is induced by the systemic administration of the vascular endothelial growth factor and the epidermal growth factor. Blood (2000) 1.03
In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase. Hum Gene Ther (1997) 1.03
Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma. Am J Pathol (1995) 1.03
Macrophage-derived growth factor for fibroblasts and Interleukin-1 are distinct entities. J Leukoc Biol (1984) 1.02
Single-radial-hemolysis test for the assay of rubella antibody in antenatal, vaccinated, and rubella virus-infected patients. J Infect Dis (1979) 1.02
Vascular endothelial growth factor induces heparin-binding epidermal growth factor-like growth factor in vascular endothelial cells. J Biol Chem (1998) 1.01
Lateralization of brainstem lesions by brainstem auditory evoked potentials. Neurology (1981) 1.01
Malignant human gliomas express an amiloride-sensitive Na+ conductance. Am J Physiol (1999) 1.00
Fas-induced expression of chemokines in human glioma cells: involvement of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase. Cancer Res (2001) 0.99
Receptor for interleukin 13 is abundantly and specifically over-expressed in patients with glioblastoma multiforme. Int J Oncol (1999) 0.99
Clonal spread of SCCmec type IV methicillin-resistant Staphylococcus aureus between community and hospital. Clin Microbiol Infect (2007) 0.99
Altered subcellular localization of suppressin, a novel inhibitor of cell-cycle entry, is an independent prognostic factor in colorectal adenocarcinomas. Clin Cancer Res (2001) 0.99
Extracranial vertebral artery stent placement: in-hospital and follow-up results. J Neurosurg (1999) 0.98
Involvement of the cervical spine in rheumatoid arthritis. Arthritis Rheum (1989) 0.98
Toxic amblyopia from ibuprofen. Br Med J (1972) 0.97
Angioplasty and stenting for restenosis after carotid endarterectomy. Initial experience. Stroke (1996) 0.97
Removal of viscoelastic materials after experimental cataract surgery in vitro. J Cataract Refract Surg (1992) 0.96
Wisconsin Card Sorting performance in patients with temporal lobe epilepsy: clinical and neuroanatomical correlates. Epilepsia (2000) 0.96
Iris atrophy after quinine amblyopia. Arch Ophthalmol (1966) 0.95
Using elderly educators to increase colorectal cancer screening. Gerontologist (1993) 0.95
VEGF-D is an X-linked/AP-1 regulated putative onco-angiogen in human glioblastoma multiforme. Mol Med (2001) 0.95